orforglipron ldl
Experts Question Semaglutide’s LDL Efficacy vs Orforglipron?
Orforglipron lowered LDL cholesterol by 12% in a head-to-head trial, outpacing semaglutide’s 9% drop, raising questions about which GLP-1 agent best protects cardiovascular health. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.